Logo image of MAR

MARRIOTT INTERNATIONAL -CL A (MAR) Stock Fundamental Analysis

NASDAQ:MAR - Nasdaq - US5719032022 - Common Stock - Currency: USD

267.34  -5.85 (-2.14%)

After market: 267.3 -0.04 (-0.01%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MAR. MAR was compared to 135 industry peers in the Hotels, Restaurants & Leisure industry. While MAR belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. While showing a medium growth rate, MAR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

MAR had positive earnings in the past year.
MAR had a positive operating cash flow in the past year.
Of the past 5 years MAR 4 years were profitable.
MAR had a positive operating cash flow in each of the past 5 years.
MAR Yearly Net Income VS EBIT VS OCF VS FCFMAR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

MAR has a better Return On Assets (9.29%) than 82.96% of its industry peers.
The Return On Invested Capital of MAR (17.73%) is better than 88.15% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MAR is above the industry average of 14.12%.
The 3 year average ROIC (17.69%) for MAR is below the current ROIC(17.73%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.29%
ROE N/A
ROIC 17.73%
ROA(3y)10.19%
ROA(5y)6.76%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)17.69%
ROIC(5y)12.83%
MAR Yearly ROA, ROE, ROICMAR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400

1.3 Margins

MAR's Profit Margin of 9.75% is fine compared to the rest of the industry. MAR outperforms 73.33% of its industry peers.
In the last couple of years the Profit Margin of MAR has grown nicely.
MAR's Operating Margin of 15.40% is fine compared to the rest of the industry. MAR outperforms 68.89% of its industry peers.
MAR's Operating Margin has improved in the last couple of years.
MAR has a worse Gross Margin (20.31%) than 85.19% of its industry peers.
In the last couple of years the Gross Margin of MAR has grown nicely.
Industry RankSector Rank
OM 15.4%
PM (TTM) 9.75%
GM 20.31%
OM growth 3Y6.48%
OM growth 5Y10.63%
PM growth 3Y6.06%
PM growth 5Y9.28%
GM growth 3Y0.18%
GM growth 5Y5.79%
MAR Yearly Profit, Operating, Gross MarginsMAR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

More info and screens

4

2. Health

2.1 Basic Checks

MAR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
MAR has less shares outstanding than it did 1 year ago.
The number of shares outstanding for MAR has been reduced compared to 5 years ago.
The debt/assets ratio for MAR is higher compared to a year ago.
MAR Yearly Shares OutstandingMAR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
MAR Yearly Total Debt VS Total AssetsMAR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

MAR has an Altman-Z score of 3.61. This indicates that MAR is financially healthy and has little risk of bankruptcy at the moment.
MAR has a Altman-Z score of 3.61. This is amongst the best in the industry. MAR outperforms 82.22% of its industry peers.
The Debt to FCF ratio of MAR is 8.18, which is on the high side as it means it would take MAR, 8.18 years of fcf income to pay off all of its debts.
MAR has a Debt to FCF ratio of 8.18. This is in the better half of the industry: MAR outperforms 63.70% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 8.18
Altman-Z 3.61
ROIC/WACC2.01
WACC8.81%
MAR Yearly LT Debt VS Equity VS FCFMAR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

A Current Ratio of 0.45 indicates that MAR may have some problems paying its short term obligations.
The Current ratio of MAR (0.45) is worse than 77.04% of its industry peers.
MAR has a Quick Ratio of 0.45. This is a bad value and indicates that MAR is not financially healthy enough and could expect problems in meeting its short term obligations.
MAR has a worse Quick ratio (0.45) than 71.85% of its industry peers.
Industry RankSector Rank
Current Ratio 0.45
Quick Ratio 0.45
MAR Yearly Current Assets VS Current LiabilitesMAR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

4

3. Growth

3.1 Past

MAR shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.36%.
The Earnings Per Share has been growing by 9.22% on average over the past years. This is quite good.
The Revenue has been growing slightly by 5.45% in the past year.
The Revenue has been growing slightly by 3.66% on average over the past years.
EPS 1Y (TTM)-5.36%
EPS 3Y43.21%
EPS 5Y9.22%
EPS Q2Q%8.92%
Revenue 1Y (TTM)5.45%
Revenue growth 3Y21.9%
Revenue growth 5Y3.66%
Sales Q2Q%4.79%

3.2 Future

Based on estimates for the next years, MAR will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.04% on average per year.
MAR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.11% yearly.
EPS Next Y8.03%
EPS Next 2Y10.88%
EPS Next 3Y11.33%
EPS Next 5Y14.04%
Revenue Next Year4.83%
Revenue Next 2Y5.33%
Revenue Next 3Y5.12%
Revenue Next 5Y4.11%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
MAR Yearly Revenue VS EstimatesMAR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B
MAR Yearly EPS VS EstimatesMAR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 5 10 15 20

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 28.05, the valuation of MAR can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of MAR is on the same level as its industry peers.
MAR's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.60.
Based on the Price/Forward Earnings ratio of 23.28, the valuation of MAR can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MAR is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of MAR to the average of the S&P500 Index (22.43), we can say MAR is valued inline with the index average.
Industry RankSector Rank
PE 28.05
Fwd PE 23.28
MAR Price Earnings VS Forward Price EarningsMAR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MAR indicates a slightly more expensive valuation: MAR is more expensive than 66.67% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as MAR.
Industry RankSector Rank
P/FCF 39.99
EV/EBITDA 19.73
MAR Per share dataMAR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MAR does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of MAR may justify a higher PE ratio.
PEG (NY)3.49
PEG (5Y)3.04
EPS Next 2Y10.88%
EPS Next 3Y11.33%

More info and screens

5

5. Dividend

5.1 Amount

MAR has a yearly dividend return of 0.99%, which is pretty low.
MAR's Dividend Yield is a higher than the industry average which is at 3.55.
Compared to an average S&P500 Dividend Yield of 2.36, MAR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.99%

5.2 History

The dividend of MAR has a limited annual growth rate of 5.43%.
MAR has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of MAR decreased in the last 3 years.
Dividend Growth(5Y)5.43%
Div Incr Years2
Div Non Decr Years2
MAR Yearly Dividends per shareMAR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

MAR pays out 28.47% of its income as dividend. This is a sustainable payout ratio.
The dividend of MAR is growing, but earnings are growing more, so the dividend growth is sustainable.
DP28.47%
EPS Next 2Y10.88%
EPS Next 3Y11.33%
MAR Yearly Income VS Free CF VS DividendMAR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B
MAR Dividend Payout.MAR Dividend Payout, showing the Payout Ratio.MAR Dividend Payout.PayoutRetained Earnings

More info and screens

MARRIOTT INTERNATIONAL -CL A

NASDAQ:MAR (5/20/2025, 8:13:36 PM)

After market: 267.3 -0.04 (-0.01%)

267.34

-5.85 (-2.14%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)07-29 2025-07-29/bmo
Inst Owners62.36%
Inst Owner Change0.33%
Ins Owners1.23%
Ins Owner Change0.27%
Market Cap73.62B
Analysts70
Price Target277.95 (3.97%)
Short Float %2.34%
Short Ratio2.44
Dividend
Industry RankSector Rank
Dividend Yield 0.99%
Yearly Dividend2.4
Dividend Growth(5Y)5.43%
DP28.47%
Div Incr Years2
Div Non Decr Years2
Ex-Date05-23 2025-05-23 (0.67)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.89%
Min EPS beat(2)1.8%
Max EPS beat(2)1.98%
EPS beat(4)3
Avg EPS beat(4)0.21%
Min EPS beat(4)-3.05%
Max EPS beat(4)1.98%
EPS beat(8)5
Avg EPS beat(8)8.35%
EPS beat(12)8
Avg EPS beat(12)8.23%
EPS beat(16)11
Avg EPS beat(16)14.98%
Revenue beat(2)1
Avg Revenue beat(2)0.16%
Min Revenue beat(2)-0.2%
Max Revenue beat(2)0.53%
Revenue beat(4)1
Avg Revenue beat(4)-0.64%
Min Revenue beat(4)-1.66%
Max Revenue beat(4)0.53%
Revenue beat(8)2
Avg Revenue beat(8)-0.69%
Revenue beat(12)5
Avg Revenue beat(12)0.85%
Revenue beat(16)8
Avg Revenue beat(16)1.39%
PT rev (1m)-6.41%
PT rev (3m)-1.5%
EPS NQ rev (1m)-4.91%
EPS NQ rev (3m)-5.64%
EPS NY rev (1m)-1.59%
EPS NY rev (3m)-3.07%
Revenue NQ rev (1m)-1.37%
Revenue NQ rev (3m)-1.9%
Revenue NY rev (1m)-0.47%
Revenue NY rev (3m)-1.27%
Valuation
Industry RankSector Rank
PE 28.05
Fwd PE 23.28
P/S 2.9
P/FCF 39.99
P/OCF 28.13
P/B N/A
P/tB N/A
EV/EBITDA 19.73
EPS(TTM)9.53
EY3.56%
EPS(NY)11.48
Fwd EY4.29%
FCF(TTM)6.69
FCFY2.5%
OCF(TTM)9.5
OCFY3.55%
SpS92.19
BVpS-11.5
TBVpS-78.31
PEG (NY)3.49
PEG (5Y)3.04
Profitability
Industry RankSector Rank
ROA 9.29%
ROE N/A
ROCE 21.28%
ROIC 17.73%
ROICexc 18.25%
ROICexgc N/A
OM 15.4%
PM (TTM) 9.75%
GM 20.31%
FCFM 7.25%
ROA(3y)10.19%
ROA(5y)6.76%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)17.69%
ROIC(5y)12.83%
ROICexc(3y)18.12%
ROICexc(5y)13.24%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)21.24%
ROCE(5y)15.4%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y31.33%
ROICexc growth 5Y16%
OM growth 3Y6.48%
OM growth 5Y10.63%
PM growth 3Y6.06%
PM growth 5Y9.28%
GM growth 3Y0.18%
GM growth 5Y5.79%
F-Score6
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 8.18
Debt/EBITDA 3.16
Cap/Depr 138.57%
Cap/Sales 3.06%
Interest Coverage 6.13
Cash Conversion 58.56%
Profit Quality 74.35%
Current Ratio 0.45
Quick Ratio 0.45
Altman-Z 3.61
F-Score6
WACC8.81%
ROIC/WACC2.01
Cap/Depr(3y)144.45%
Cap/Depr(5y)104.73%
Cap/Sales(3y)2.16%
Cap/Sales(5y)1.82%
Profit Quality(3y)86.15%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.36%
EPS 3Y43.21%
EPS 5Y9.22%
EPS Q2Q%8.92%
EPS Next Y8.03%
EPS Next 2Y10.88%
EPS Next 3Y11.33%
EPS Next 5Y14.04%
Revenue 1Y (TTM)5.45%
Revenue growth 3Y21.9%
Revenue growth 5Y3.66%
Sales Q2Q%4.79%
Revenue Next Year4.83%
Revenue Next 2Y5.33%
Revenue Next 3Y5.12%
Revenue Next 5Y4.11%
EBIT growth 1Y1.37%
EBIT growth 3Y29.79%
EBIT growth 5Y14.68%
EBIT Next Year30.19%
EBIT Next 3Y13.74%
EBIT Next 5Y13.02%
FCF growth 1Y-25.59%
FCF growth 3Y26.22%
FCF growth 5Y14.14%
OCF growth 1Y-8.24%
OCF growth 3Y32.68%
OCF growth 5Y10.28%